CYP7A1 and atherosclerosis: Third, in the liver, TMAO could reduce the expression of cytochrome P450 family 7 subfamily A member 1 (CYP7A1), a key enzyme in cholesterol metabolism, which is associated with reduced expression and synthesis of bile acids, decreased bile acid distribution, and increased atherosclerosis.